Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
DeciBio News
Clinical Diagnostics
DeciBio Forecasts the Global Clinical Oncology Biomarker Testing Market to grow at 13% p.a., reaching ~$12.6B in 2028 - Market Report by DeciBio Consulting LLC
Global Clinical Oncology Biomarker Testing Market Report, Second Edition: 2023-2028
January 3, 2024
DeciBio News
Clinical Diagnostics
DeciBio Forecasts the Global Clinical Oncology Biomarker Testing Market to grow at 13% p.a., reaching ~$12.6B in 2028 - Market Report by DeciBio Consulting LLC
Global Clinical Oncology Biomarker Testing Market Report, Second Edition: 2023-2028
January 3, 2024
Biomarkers
Immuno-Oncology
Clinical Diagnostics
.png)
In The Press
Research Tools
Digital pathology and AI—drivers, budgets, and jobs
DeciBio's Katie Gillette comments on the digital pathology space.
December 20, 2023
In The Press
Research Tools
Digital pathology and AI—drivers, budgets, and jobs
DeciBio's Katie Gillette comments on the digital pathology space.
December 20, 2023
Digital Pathology
AI / Machine Learning
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | November Roundup 2023
Liquid Biopsy (LBx) continued to develop through November, featuring new clinical and research collaborations as well as trial launches and study results.
December 11, 2023
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | November Roundup 2023
Liquid Biopsy (LBx) continued to develop through November, featuring new clinical and research collaborations as well as trial launches and study results.
December 11, 2023
Liquid Biopsy
Blog Article
Clinical Diagnostics
2023 Partnership Update - An Adoption Inflection on the Horizon
In this post, we will be looking back at the 2023 partnership landscape to understand what it might mean for 2024 and beyond.
December 6, 2023
Blog Article
Clinical Diagnostics
2023 Partnership Update - An Adoption Inflection on the Horizon
In this post, we will be looking back at the 2023 partnership landscape to understand what it might mean for 2024 and beyond.
December 6, 2023
Digital Pathology
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | November Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of November.
December 1, 2023
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | November Roundup 2023
Read about the latest updates in the Next-Generation Therapeutics space in the month of November.
December 1, 2023
Next-Generation Therapeutics
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
DeciBio Q&A
Exploring the Frontier of Multiomics: DeciBio Q&A with Peter Fromen, CEO of biomodal
A Q&A with Peter Fromen, CEO of biomodal, emphasizing the potential applications of their technology, particularly in oncology, liquid biopsy, aging, and neurodegenerative disorders.
November 28, 2023
Liquid Biopsy
Genomics Market
multiomics
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved